Clinical decision support vendor PeriGen Inc. has named Matthew Sappern as CEO. He succeeds Donald Deieso, who accepted a position with Arsenal Capital Partners.

Sappern most recently served as senior vice president of client sales at Allscripts; he was senior vice president of professional services at hospital vendor Eclipsys before Allscripts acquired it. He also served at WebMD, Time Warner, Primedia and Young & Rubicam.

Princeton, N.J.-based PeriGen sells the PeriCALM fetal monitoring system and the PeriBirth clinical decision support software.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access